GMF Capital

GMF Capital LLC is a private equity firm established in 2013, headquartered in New York, with additional offices in Baltimore and Wollerau, Switzerland. The firm specializes in private equity and alternative investments, focusing primarily on the real estate and healthcare sectors, as well as structured credit. GMF Capital employs a management platform that leverages its extensive experience and a proprietary network of relationships to identify and execute investment opportunities. The firm aims to achieve superior risk-adjusted returns through cash-flowing investments that emphasize liquidity and exhibit limited exposure to cyclical volatility.

Fegel, Gary

Founder

6 past transactions

sMiles

Seed Round in 2022
sMiles is a platform that enables users to earn Bitcoin through everyday activities such as walking, shopping, playing games, and completing surveys. It employs a gamified approach to incentivize user engagement, rewarding participants with fractional Bitcoin for their activities. By utilizing network technology and a backend system designed for micro-incentives, sMiles connects location sponsors with users, allowing advertisers to allocate budgets directly to individuals. This strategy not only fosters customer loyalty but also encourages users to participate in their daily routines while earning cryptocurrency.

Pardes Biosciences

Post in 2021
Pardes Biosciences is a clinical-stage biopharmaceutical company focused on addressing significant health challenges, particularly those posed by viral infections. It utilizes modern reversible-covalent chemistry to discover and develop novel oral drug candidates. The company's lead product candidate, PBI-0451, is an oral antiviral designed to treat and prevent infections from SARS-CoV-2, the virus responsible for COVID-19. By reimagining the patient journey, Pardes aims to provide accessible and convenient treatment options for both adult and pediatric patients, ultimately striving to improve health outcomes and respond effectively to global health crises.

My Sky

Funding Round in 2020
My Sky SA specializes in developing a spend management platform tailored for the aviation industry, offering solutions designed for asset managers, asset owners, and corporate flight departments. Founded in 2016 and headquartered in Lausanne, Switzerland, with additional offices in New York and Moscow, the company provides automated financial and accounting processes, enhancing transparency and independent verification for jet owners. Its innovative platform digitizes, verifies, analyzes, and stores financial information, ensuring instant access to critical data. My Sky's commitment to Swiss standards of efficiency and data security underscores its independence from market influences, allowing it to focus on optimizing asset management for business aircraft owners. Since its public launch in 2015, My Sky has gained recognition in Europe and the CIS, receiving several prestigious awards for its contributions to the aviation sector. With a team of over 80 experts, including auditors and IT specialists, My Sky aims to revolutionize jet ownership through technology and expertise, while steadily expanding its global presence in the business aviation market.

InterCure

Post in 2018
InterCure is a medical device company that has developed and patented a technology platform for respiratory-based treatment of cardiovascular and pulmonary diseases. The Company has incorporated its "Interactive Respiratory-Pacing" technology platform into several product lines, the first two of which offer a new therapeutic class of non-drug treatments for two of the most widespread and costly disease states in the healthcare industry: hypertension and heart failure. InterCure’s first market-ready product, RESPeRATE, is the only FDA-cleared, medical device clinically proven to lower high blood pressure with no side effects. InterCure's heart failure product, InTone™ has successfully completed phase 2a efficacy clinical trials and is expected to be launched when it completes the regulatory approval process. With its outstanding management team, the board of directors and a world-class Scientific Advisory Board, Intercure is poised to become the market leader in patient-focused medical devices that provide non-drug, no-side-effect treatment for some of the world's most prevalent and costly chronic conditions. InterCure was founded in 1994 and is headquartered in Ra'anana, Israel.

TouchSpin Gaming AG

Seed Round in 2014
TouchSpin Gaming has created a patented, multiplayer slot platform called TouchSpin Casino. Our first release on the platform is a social casino game called Texas Reels. This is a social, multiplayer slot game for the free to play casual games audience and hybridizes poker and slots. Texas Reels is based on our patented mutliplayer slot mechanic, that let’s you bet against other players sitting with you at the table. All bets go into the pot, like poker, and the winner takes all. TouchSpin Gaming is re-imagining the social casino platform. With revolutionary new slots interfaces, fast and easy game play, powerups and complete meta-game, we’ve created a thrilling new casino game experience, especially for Millienials. The TouchSpin Casino team is managed by technology and gaming professionals who are passionate about creating the next big thing in the casino slot experience. We have put our many years of industry experience into the development of what we believe is the multiplayer casino platform that will redefine the slots category.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.